Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 12, 2003New England Journal of MedicineOpen Access

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

FBFilip BaertAZ DeltaMNMaja NomanUniversity of Chittagong
Séverine Vermeire
Séverine VermeireKU Leuven

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Baert et al. (2003) studied this question.

synapsesocial.com/papers/69da22d1ba6014a02e835defhttps://doi.org/10.1056/nejmoa020888
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease1999 · 2,766 citations
  2. 2Infliximab in Crohn's Disease: First Anniversary Clinical Experience2000 · 235 citations
  3. 3Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease2000 · 212 citations
  4. 4A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease1997 · 3,167 citations
  5. 5Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience2001 · 55 citations